
Lorundrostat LAUNCH-HTN Trial
We would love to hear your thoughts on the episodes! Dr Thomas Nero discusses the new aldosterone synthase inhibitor Lorundrostat with Dr Liffert Vogt and the outcomes from the Launch HTN trial.

Loading…

Hosted by Thomas Nero MD FACC · 🇺🇸 US · EN-US · 23 episodes
Established thought leaders with verified media credentials.
Investigating Innovative Cardiovascular Research at the Intersection of Academic Theory and Clinical Practice. In these discussions we take a deep dive into the latest research and how it informs current practice. For a patient level discussion, please listen to PATIENT PULSE. Available on Apple Podcasts, Spotify, YouTube and most other services. Subscribe to have new podcasts sent directly to your player and please email us with any comments. We would love to hear from you.
Thomas Nero MD FACC hosts Future Pulse Cardiology, a health show with 23 episodes published.

We would love to hear your thoughts on the episodes! Dr Thomas Nero discusses the new aldosterone synthase inhibitor Lorundrostat with Dr Liffert Vogt and the outcomes from the Launch HTN trial.

We would love to hear your thoughts on the episodes! Dr Thomas Nero discusses inflammation adn specifically the role of rheumatologic disorders on coronary artery disease with Dr Nehal Mehta. This conversation delves int

We would love to hear your thoughts on the episodes! In this conversation, Dr. Nehal Mehta and Dr. Thomas Nero discuss the critical relationship between systemic inflammation and cardiovascular health, particularly in pa

We would love to hear your thoughts on the episodes! Prof. Stefan Neubauer and Dr. Thomas Nero discuss two recent papers on the utility of coronary inflammation imaging on CT coronary angiography with Fat Attenuation Ind

We would love to hear your thoughts on the episodes! Dr Gibson and Dr Nero discuss the oft maligned issue of medical statistics. Their discussion covers the pros and cons of traditional Cox proportional hazards regressio

We would love to hear your thoughts on the episodes! This episode is a deep dive into Lipoprotein a with Dr Steven Nissen from the Cleveland Clinic. He and Dr Nero discuss the genetics of Lp(a), its pathophysiology, curr

We would love to hear your thoughts on the episodes! Dr Steven Nissen from the Cleveland Clinic discuses with Dr. Thomas Nero the basic clinical approach to Lp(a) with need for routine testing and a few simple case studi

We would love to hear your thoughts on the episodes! Dr Thomas Nero speaks with Dr Aaron Baggish about coronary artery disease in the endurance athlete (and non-athlete as well!) They discuss cardiovascular testing in Ma

We would love to hear your thoughts on the episodes! Dr Mandrola discusses recent trail data with Dr. Thomas Nero including the results from Artesia, NOAH Afnet 6, Frail AF, Azalea and Oceanic-AF. They also discuss Left

We would love to hear your thoughts on the episodes! Dr. Thomas Nero speaks with Dr. Mathew Budoff about Coronary Calcium Scoring, CT Coronary Angiography and cardiovascular outcomes. The discussion goes beyond basic ris

We would love to hear your thoughts on the episodes! Dr. Elizabeth Ofili discusses the African American Heart Study with Dr. Thomas Nero. They also discuss her work at the NIH and the African American Heart Failure Trial

We would love to hear your thoughts on the episodes! Dr. Thomas Nero discusses current therapy with Factor X inhibitors, the new research with Factor XI inhibition and specifically the enrolling Milvexian clinical trials

We would love to hear your thoughts on the episodes! Dr. Thomas Nero speaks with Dr Peter Toth about the dramatic change occuring in diabtetes management and its effect on cardiovascular disease. Starting with the bioche

We would love to hear your thoughts on the episodes! Dr. Thomas Nero speaks with Dr. Peter Toth about the complex biology of lipids and atherosclerosis. In this episode Dr Toth dives into LDL goals, therapies for attenua

We would love to hear your thoughts on the episodes! Dr Paul Ridker discusses his paper on residual inflammatory risk that was recently published in the Lancet with Dr. Thomas Nero. He discusses the pathology of inflamma

We would love to hear your thoughts on the episodes! Dr Christopher Cannon discusses the potential of Pragmatic Clinical Trials in our research armamentarium with Dr. Thomas Nero. They review the EVOLVE-MI trial for Earl

We would love to hear your thoughts on the episodes! Dr Sharoanne Hayes and Dr. Thomas Nero continue their discussion of SCAD focusing on genetics, trial design and the role of online registries as well as the holistic t

We would love to hear your thoughts on the episodes! Dr Sharonne Hayes of the May Clinic discusses SCAD with Dr. Thomas Nero. Initially focusing on the new treatment paradigms, their wide ranging discussion covers etiolo

We would love to hear your thoughts on the episodes! Dr. Nero discusses evaluation of coronary artery disease and coronary inflammaiton with Dr. Cheerag Shirodaria from the University of Oxford. Dr. Shirodaria along with

We would love to hear your thoughts on the episodes! Prof. Christine Coughlin of Wake Forest School of Law speaks with Dr. Thomas Nero on the FDA approval process, emergency use authorization, Right to Try Legislation an
Steven Nissen
Cleveland Clinic
1 appearance on this show
Dr. Steven Nissen
Cleveland Clinic
1 appearance on this show
Dr Aaron Baggish
Université de Lausanne
1 appearance on this show
Dr. Sharonne Hayes
May Clinic
1 appearance on this show
Dr. Cheerag Shirodaria
University of Oxford
1 appearance on this show
Prof. Charalambos Antonidies
Caristo Diagnostics
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.








Future Pulse Cardiology has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Future Pulse Cardiology is hosted by Thomas Nero MD FACC. The show is categorised under health (fitness) and has published 23 episodes.
Future Pulse Cardiology has published 23 episodes.
Future Pulse Cardiology regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
Future Pulse Cardiology is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Future Pulse Cardiology hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Future Pulse Cardiology average 32 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Future Pulse Cardiology's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.